{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/radiogenomics-peer-reviewed-journal-article-featuring-fortrea-oncologists#webpage",
"url": "https://www.fortrea.com/insights/radiogenomics-peer-reviewed-journal-article-featuring-fortrea-oncologists",
"name": "Radiogenomics: Peer-reviewed Journal Article Featuring Fortrea Oncologists",
"description": "This Fortrea infosheet explores how radiogenomics is advancing precision oncology and modern cancer research through the integration of medical imaging and genomic analysis. The content focuses on radiogenomics applications related to genomic profiling, imaging biomarkers, personalized cancer treatment, and biomarker-driven oncology research across evolving oncology programs. The infosheet highlights how linking imaging characteristics with genomic behavior can support improved understanding of tumor biology, patient selection, treatment response assessment, and precision oncology research strategies. Fortrea oncologists discuss scientific insights and peer-reviewed research contributing to the growing role of radiogenomics within precision oncology and cancer research environments. By integrating imaging data with genomic analysis and biomarker-focused oncology research, the infosheet provides insights into emerging approaches influencing personalized cancer treatment and precision oncology development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radiogenomics: Peer-reviewed Journal Article Featuring Fortrea Oncologists",
"item": "https://www.fortrea.com/insights/radiogenomics-peer-reviewed-journal-article-featuring-fortrea-oncologists"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/radiogenomics-peer-reviewed-journal-article-featuring-fortrea-oncologists#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/radiogenomics-peer-reviewed-journal-article-featuring-fortrea-oncologists#webpage"
},
"headline": "Radiogenomics in Precision Oncology and Cancer Research | Fortrea Infosheet",
"description": "This Fortrea infosheet explores how radiogenomics is advancing precision oncology and modern cancer research through the integration of medical imaging and genomic analysis. The content focuses on radiogenomics applications related to genomic profiling, imaging biomarkers, personalized cancer treatment, and biomarker-driven oncology research across evolving oncology programs. The infosheet highlights how linking imaging characteristics with genomic behavior can support improved understanding of tumor biology, patient selection, treatment response assessment, and precision oncology research strategies. Fortrea oncologists discuss scientific insights and peer-reviewed research contributing to the growing role of radiogenomics within precision oncology and cancer research environments. By integrating imaging data with genomic analysis and biomarker-focused oncology research, the infosheet provides insights into emerging approaches influencing personalized cancer treatment and precision oncology development.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-12",
"dateModified": "2025-07-12",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/radiogenomics-peer-reviewed-fortrea-oncologists-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}